echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Health care products chaos repeatedly banned more than the market will usher in high-frequency rectification

    Health care products chaos repeatedly banned more than the market will usher in high-frequency rectification

    • Last Update: 2021-02-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The number of health care products enterprises in China is far more than pharmaceutical enterprises, but mainly small enterprises, it is difficult to control, product quality has not buckled seat belt. To this end, the State Administration of Food and Drug Administration began to focus on the health care products industry, all over the investigation and prosecution action, it is expected that the health care products market will experience a period of high-frequency rectification.Frequent rectification
    Recently, Hebei Tangshan Food and Drug Administration in the city-wide launched a three-month "health care products shop" inventory and rectification work, rectification and standardization of "health care products shop" food (health food), medicine, medical equipment operations. In fact, Tangshan Food and Drug Administration is not the first department to open up the health care products market. Since this year, a number of provinces and autonomous regions, including Beijing and Guangxi, have launched corrective actions in the field of health care products circulation.
    understand that China's health care products market continues to expand, the market size has increased to 450 billion yuan in 2015. At the same time, false propaganda, quality and safety issues caused by the market chaos. It is not uncommon to produce and sell fake health care products, to add Western medicines to health care products, to exaggerate the efficacy of health care products, and to replace medicines with health care products.
    , the health care industry has been hit hard from production to circulation, following last year's "strictest clinical trial data in history." In April, the State Administration of Food and Drug Administration issued the "2016 General Administration of Food and Drug Administration key sampling food production enterprises list notice", the circular covers 40 health food enterprises, including six pharmaceutical companies, health hall subsidiary Hainan Health Hall Pharmaceutical Co., Ltd. and other leading enterprises.
    July 1, the Measures for the Registration and Filing of Health Food were officially implemented, which means that the management methods for health food have changed from a single registration system to a combination of registration and filing, and the promotion of self-discipline in production enterprises.scope of
    reporters combed found that the state's supervision of the health care industry mainly comes from two aspects: illegal addition and false propaganda. An industry insider, who did not want to be named, said that the focus of the health care industry consolidation will still be placed on these two aspects, the future rectification will also be extended to health food licensing qualifications, product quality and safety, advertising, Internet operations and illegal marketing.
    past, there was not much of a mess in the health care industry. In 2011, the Jiangsu Food and Drug Administration announced that 12 kinds of health food products were detected as illegally added drug ingredients; In 2013, the Anhui Food and Drug Administration identified 13 kinds of health food illegally added phenol, tadalafei, sidnaphony or sibuqumin these countries expressly prohibited the addition of pharmaceutical ingredients; In 2015, the Guangdong Food and Drug Administration announced that 25 batches of health food were illegally added to the investigation.
    In terms of false propaganda, in 2013 the State Administration of Food and Drug Administration issued a public notice to Shaanxi Renkang Pharmaceuticals, Shanghai Defengtang Biotech, Beijing Jiandu Pharmaceuticals and other 32 health food document holders (persons) with serious illegal advertising; In 2015, the State Administration of Food and Drug Administration announced that the contents of health food advertisements produced by Beijing Yitang Health Food Co., Ltd. and Beijing Jinsheng Health Industry Biotechnology Co., Ltd. contain unscientific claims of efficacy, exaggerate the efficacy of health food or expand the scope of suitable population, and deceive and mislead consumers to inform.Sustainable Supervision
    " at present, China's health food production industry has more than 2500 batch number holding enterprises, more than 15,000 product approvals, more than 5000 health care products on the market. Jia Yaguang, vice president of the China Health Association, said.
    In fact, the domestic market health care products enterprises far more than pharmaceutical enterprises, a rough estimate of 50,000-60,000 production enterprises, most of these enterprises are small, or even have no business license qualifications, but because some small enterprises "one shot for one place" is difficult to control.
    Tangshan Food and Drug Administration of this rectification specifically includes, in the field of food circulation, strictly check whether the undocumented operation of food, whether the operation of illegal addition of drugs of food; In the field of pharmaceutical equipment, strictly check whether the operation of drugs without a license, whether the operation of counterfeit drugs inferior drugs; whether to operate medical devices without obtaining a medical device license or for the record, or whether to operate medical devices without a product registration certificate; In the field of health food, strictly check whether the operation of health food without a license, whether the operation of counterfeit health food, whether the operation of illegal addition of drugs of health food.
    shi Lichen, head of The Beijing Dingchen Medical Advisory Center, said that some health care products-related policies have been put in place to a certain extent to rectify the health care products market, but not thorough enough, the strong supervision of this market can not be short-term behavior. (Health Weekly)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.